Abstract | BACKGROUND: METHODS: Consecutive OMG patients from a single institution over a 16-year period and treated with ≥1 month of daily prednisone were included. Steroid-related complications were defined as the development/worsening of conditions requiring alteration to medical therapy. Serious complications included conditions requiring emergency care, hospitalization, or surgery. RESULTS: Eighty-three patients with follow-up period ranging from 1 to 271 months (median, 58 months) were included. Fifty-eight (70%) patients had follow-up period of ≥24 months. The maximum prednisone dose ranged from 10 to 60 mg. Tapering to ≤10 mg/d required ≤4 months for all but 2 patients. Median average daily dose following the initial course was 5 mg daily (interquartile range, 4-7.5 mg). During the first 2 years, there were 24.5 complications per 100 person-years. Only one patient had a serious complication within the first 2 years (2-year cumulative risk, 1%), but this individual was not following the recommended regimen. CONCLUSIONS: Low-dose prednisone for OMG has an acceptable side-effect profile and causes few serious complications (2-year risk, ∼1%). However, patients need monitoring to detect the relatively common, but less serious, complications (2-year risk, ∼39%) to adjust medical therapy in a timely fashion.
|
Authors | Beau B Bruce, Mark J Kupersmith |
Journal | Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
(J Neuroophthalmol)
Vol. 32
Issue 3
Pg. 212-5
(Sep 2012)
ISSN: 1536-5166 [Electronic] United States |
PMID | 22549563
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Prednisone
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Inflammatory Agents
(therapeutic use)
- Female
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Myasthenia Gravis
(drug therapy)
- Prednisone
(therapeutic use)
- Retrospective Studies
- Treatment Outcome
- Young Adult
|